Literature DB >> 19151924

Human stem cells as a model for cardiac differentiation and disease.

A Beqqali1, W van Eldik, C Mummery, R Passier.   

Abstract

Studies on identification, derivation and characterization of human stem cells in the last decade have led to high expectations in the field of regenerative medicine. Although it is clear that for successful stem cell-based therapy several obstacles have to be overcome, other opportunities lay ahead for the use of human stem cells. A more immediate application would be the development of human models for cell-type specific differentiation and disease in vitro. Cardiomyocytes can be generated from stem cells, which have been shown to follow similar molecular events of cardiac development in vivo. Furthermore, several monogenic cardiovascular diseases have been described, for which in vitro models in stem cells could be generated. Here, we will discuss the potential of human embryonic stem cells, cardiac stem cells and the recently described induced pluripotent stem cells as models for cardiac differentiation and disease.

Entities:  

Mesh:

Year:  2009        PMID: 19151924     DOI: 10.1007/s00018-009-8476-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  11 in total

Review 1.  Cardiogenesis: an embryological perspective.

Authors:  Ramón Muñoz-Chápuli; José M Pérez-Pomares
Journal:  J Cardiovasc Transl Res       Date:  2009-11-04       Impact factor: 4.132

Review 2.  Multi-scale computational models of familial hypertrophic cardiomyopathy: genotype to phenotype.

Authors:  Stuart G Campbell; Andrew D McCulloch
Journal:  J R Soc Interface       Date:  2011-08-10       Impact factor: 4.118

Review 3.  Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies.

Authors:  Evangeline Tzatzalos; Oscar J Abilez; Praveen Shukla; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2015-09-30       Impact factor: 15.470

Review 4.  Mechanisms underlying the cardiac pacemaker: the role of SK4 calcium-activated potassium channels.

Authors:  David Weisbrod; Shiraz Haron Khun; Hanna Bueno; Asher Peretz; Bernard Attali
Journal:  Acta Pharmacol Sin       Date:  2016-01       Impact factor: 6.150

Review 5.  Human stem cells and drug screening: opportunities and challenges.

Authors:  Allison D Ebert; Clive N Svendsen
Journal:  Nat Rev Drug Discov       Date:  2010-03-26       Impact factor: 84.694

Review 6.  Adult stem cells: from new cell sources to changes in methodology.

Authors:  Beatriz Pelacho; Manuel Mazo; Juan Jose Gavira; Felipe Prósper
Journal:  J Cardiovasc Transl Res       Date:  2010-12-02       Impact factor: 4.132

7.  Bisphosphonate of Zoledronate Has Antiapoptotic Effect on Hypoxia/Reoxygenation Injury in Human Embryonic Stem Cell-Derived Cardiomyocytes Through Trk Signaling Pathway.

Authors:  Hua Wang; Wen-Shu Zhao; Lin Xu
Journal:  Cell Biochem Biophys       Date:  2022-02-28       Impact factor: 2.989

Review 8.  Natural ECM as biomaterial for scaffold based cardiac regeneration using adult bone marrow derived stem cells.

Authors:  P Sreejit; R S Verma
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

9.  A COUP-TFII Human Embryonic Stem Cell Reporter Line to Identify and Select Atrial Cardiomyocytes.

Authors:  Verena Schwach; Arie O Verkerk; Mervyn Mol; Jantine J Monshouwer-Kloots; Harsha D Devalla; Valeria V Orlova; Konstantinos Anastassiadis; Christine L Mummery; Richard P Davis; Robert Passier
Journal:  Stem Cell Reports       Date:  2017-11-22       Impact factor: 7.765

10.  Signalling in sarcomeres in development and disease.

Authors:  W van Eldik; R Passier
Journal:  Neth Heart J       Date:  2013-07       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.